Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (141-150 of 466) with videos related to

Pageof 47
Sort By:
Antiviral Therapy|August 26, 2015
The impact of ribavirin plasma concentration on the efficacy of the interferon-sparing regimen, sofosbuvir and ribavirinMarianne Martinello, Ana Schteinman, Maryam Alavi, et al.
Journal of Viral Hepatitis|February 27, 2023
Liver-related mortality among people with hepatitis B and C: Evaluation of definitions based on linked healthcare administrative datasetsSyed Hassan Bin Usman Shah, Maryam Alavi, Behzad Hajarizadeh, et al.
Journal of Hepatology|July 1, 2018
The removal of DAA restrictions in Europe - One step closer to eliminating HCV as a major public health threatAlison D Marshall, Jean-Michel Pawlotsky, Jeffrey V Lazarus, et al.
The International Journal on Drug Policy|June 8, 2017
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care settingPhillip Read, Rebecca Lothian, Karen Chronister, et al.
The Lancet Regional Health. Western Pacific|December 5, 2024
Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: the AusHep studyRugiatu Bah, Yumi Sheehan, Xiaoying Li, et al.
Journal of Hepatology|July 13, 2016
Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: A population-based studyMaryam Alavi, Matthew G Law, Jason Grebely, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
Evaluation of Hepatitis C Virus Core Antigen Assay in a Resource-Limited Setting in PakistanAdeel Abid, Murad Uddin, Taj Muhammad, et al.
Journal of Hepatology|August 14, 2017
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regressionReem Waziry, Behzad Hajarizadeh, Jason Grebely, et al.
American Journal of Preventive Medicine|December 16, 2006
Hepatitis C in Australia: impact of a mass media campaignBen J Smith, Adrian E Bauman, Jack Chen, et al.
Drug and Alcohol Review|May 14, 2026
Large Language Models Accurately Identify People Who Inject Drugs From Infectious Diseases Discharge Summaries in an Australian HospitalDavid Goodman-Meza, Marianne Martinello, Jeffrey Masters, et al.
Pageof 47

Showing results (141-150 of 466) with videos related to

Sort By:
Pageof 47
Antiviral Therapy|August 26, 2015
The impact of ribavirin plasma concentration on the efficacy of the interferon-sparing regimen, sofosbuvir and ribavirinMarianne Martinello, Ana Schteinman, Maryam Alavi, et al.
Journal of Viral Hepatitis|February 27, 2023
Liver-related mortality among people with hepatitis B and C: Evaluation of definitions based on linked healthcare administrative datasetsSyed Hassan Bin Usman Shah, Maryam Alavi, Behzad Hajarizadeh, et al.
Journal of Hepatology|July 1, 2018
The removal of DAA restrictions in Europe - One step closer to eliminating HCV as a major public health threatAlison D Marshall, Jean-Michel Pawlotsky, Jeffrey V Lazarus, et al.
The International Journal on Drug Policy|June 8, 2017
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care settingPhillip Read, Rebecca Lothian, Karen Chronister, et al.
The Lancet Regional Health. Western Pacific|December 5, 2024
Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: the AusHep studyRugiatu Bah, Yumi Sheehan, Xiaoying Li, et al.
Journal of Hepatology|July 13, 2016
Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: A population-based studyMaryam Alavi, Matthew G Law, Jason Grebely, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
Evaluation of Hepatitis C Virus Core Antigen Assay in a Resource-Limited Setting in PakistanAdeel Abid, Murad Uddin, Taj Muhammad, et al.
Journal of Hepatology|August 14, 2017
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regressionReem Waziry, Behzad Hajarizadeh, Jason Grebely, et al.
American Journal of Preventive Medicine|December 16, 2006
Hepatitis C in Australia: impact of a mass media campaignBen J Smith, Adrian E Bauman, Jack Chen, et al.
Drug and Alcohol Review|May 14, 2026
Large Language Models Accurately Identify People Who Inject Drugs From Infectious Diseases Discharge Summaries in an Australian HospitalDavid Goodman-Meza, Marianne Martinello, Jeffrey Masters, et al.
Pageof 47